PS Ratio: 82.48

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 82.48 is 113% above its estimated 5-year average of 38.80, around the middle of its estimated 5-year range (11.45–226.19).

As of 2026-10-06T15:12:51.815Z. 46.03% below its estimated 12-month average of 152.84.

KYMR PS Ratio Metrics

P/S vs. estimated history

At 82.48, P/S is above its estimated 6-year median — higher than 74% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Kymera Therapeutics, Inc. (KYMR)?

The P/S ratio for KYMR stock is 82.48.

Is Kymera Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 82.48 is 113% above its estimated 5-year average of 38.80, around the middle of its estimated 5-year range (11.45–226.19).

What is the estimated TTM average P/S ratio for Kymera Therapeutics, Inc. (KYMR)?

The estimated TTM average P/S ratio for KYMR stock is 152.84.

What is the estimated 3Y average P/S ratio for Kymera Therapeutics, Inc. (KYMR)?

The estimated 3Y average P/S ratio for KYMR stock is 78.68.

What is the estimated 5Y average P/S ratio for Kymera Therapeutics, Inc. (KYMR)?

The estimated 5Y average P/S ratio for KYMR stock is 38.80.

Showing the most recent 260 of 1,537 data points. The chart above shows the full history.

Related Metrics